SMAD4 and autoimmune polyendocrinopathy: To disrupt BMP signaling, we sequentially mutated Smad4, a downstream effector of BMP signaling, to generate Smad4-mutant AP tumoroids (hereafter termed APS tumoroids) (Supplementary Figure 16C and D).